PARALLAX HEALTH SCIENCES, INC. (OTCMKTS:PRLX) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM 5.03 AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS: CHANGE IN FISCAL YEAR.
On December 24, 2018, the holders of more than a majority of the voting power of the stockholders of Parallax Health Sciences, Inc., a Nevada corporation, approved the increase of its authorized shares of common stock from 250,000,000 to 500,000,000, par value $0.001 per share (the “Increase of Common Stock”). On the same day, the Board of Directors of the Company adopted the resolution to amend its Articles of Incorporation to effect the Increase of Common Stock.
The Company filed a Certificate to Accompany Amended and Restated Articles of Incorporation and the Amended and Restated Articles of Incorporation (the “Amendment”) with Nevada’s Secretary of State and requested an effective date of January 28, 2019 for the Increase of Common Stock. On January 29, 2019, the Company received a filed and stamped copy of the Amendment from the Secretary of State of Nevada, with an effective date of January 28, 2019 for the Increase of Common Stock.
About PARALLAX HEALTH SCIENCES, INC. (OTCMKTS:PRLX)
Parallax Health Sciences, Inc. focuses on personalized patient care through the use of the Company’s Compound Pharmacy (Roxsan, Inc.) and eventually through the diagnostic testing platform capable of diagnosing and monitoring various health issues. The Company’s segments include Retail Pharmacy Services (RPS) and Corporate. The RPS segment provides a range of pharmacy services, including retail, compounding and fertility medications. The Corporate segment provides management and administrative services to support the Company. The RPS segment dispenses prescription drugs, both through local channels by direct delivery, as well as mail order. The RPS segment also sells an assortment of general merchandise, including over-the-counter drugs, beauty products and cosmetics, seasonal merchandise and convenience foods, through the Company’s pharmacy. It holds interests in Quality of Life Peace of Mind (QOLPOM). The QOLPOM Hub is a personal medication dispensing and remote monitoring solution.